Evogene Integrates Agentic AI with Google Cloud to Accelerate Molecule Discovery
EVGN•Evogene completed integration of agentic AI systems within its ChemPass AI platform in collaboration with Google Cloud, enabling early-stage profiling of biological, chemical, and clinical success criteria to prioritize high-potential small molecules. This milestone aims to shorten discovery timelines, improve scalability and increase candidate success rates.
1. Milestone Achievement
Evogene has successfully integrated autonomous computational agents into its ChemPass AI platform through the collaboration with Google Cloud, marking a key milestone that embeds biological, chemical and clinical success profiling at the inception of small-molecule discovery.
2. Enhanced AI Capabilities
The enhanced AI engine leverages Google Cloud’s Gemini models and enterprise agent infrastructure to autonomously analyze structural, biological and chemical data, enabling earlier identification of molecules that meet Target Product Profile requirements and reducing downstream attrition risks.
3. Strategic Implications and Next Steps
This advancement aligns with Evogene’s goal of autonomous molecular discovery, positioning the company to accelerate its R&D pipeline, prioritize high-potential candidates, and tackle complex protein targets more efficiently in future development programs.
